Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
VERFAHREN ZUR BEHANDLUNG UND/ODER PRÄVENTION VON SCHWERWIEGENDEN KARDIOVASKULÄREN EREIGNISSEN (MACE) MIT EINER KOMBINATION AUS EINEM BET-BROMDOMÄNENINHIBITOR UND EINEM NATRIUM-ABHÄNGIGEN GLUCOSETRANSPORT-2-INHIBITOR
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2020884269
EP Publication Number
4054584
E-Number
1811210
Language
EN
PCT Number
IB20000912
Publication Date
14.09.2022 A
09.07.2025 B1
Registration Date
09.07.2025
AT Publication Date
15.07.2025
Application Date
04.11.2020
Registration Number
-
Priorities
05.11.2019
US
201962930860 P
IPC
A61K 31/517 20060101AFI20231005BHEP
Maximum Duration of Protection
04.11.2040
Owner
Resverlogix Corp.300, 4820 Richard Road SW Calgary, AB T3E 6L1CA
Representative
No representatives present
Inventor
LEBIODA, Kenneth Eugene216 Elbow Ridge Haven Calgary, AB T3Z 3T2CA
HALLIDAY, Christopher Ross Armstrong403 138 18 Avenue SE Calgary, AB T2G 5P9CA
KHAN, Aziz Naeem317 - 5115 Richard Road SW Calgary, AB T3E 7M7CA